quinoxalines has been researched along with Nausea in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.09) | 18.7374 |
| 1990's | 1 (4.55) | 18.2507 |
| 2000's | 5 (22.73) | 29.6817 |
| 2010's | 13 (59.09) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, M; Evon, DM; Lok, AS; Michael, L; Nelson, DR; Peter, J; Reeve, BB; Stewart, PW | 1 |
| Gibbons, RD; Mann, JJ | 1 |
| Barrios, M; Cicero, A; Cristóbal, M; Jiménez-Ruiz, CA; Mayayo, M; Peña, S; Perera, L | 1 |
| Brinn, MP; Carson, KV; Edwards, D; Esterman, AJ; Fitridge, R; Goldsworthy, S; Hnin, KM; Jannes, J; Koblar, SA; Litt, J; Peters, MJ; Singh, K; Smith, BJ; Veale, AJ | 1 |
| Abrisqueta, P; Bentzien, F; Egile, C; Jiang, J; Papadopoulos, KP; Rasco, D; Ruiz-Soto, R; Shi, W; Tabernero, J; Vose, JM | 1 |
| Barr, E; Ben Ari, Z; Brown, DD; Butterton, JR; DiNubile, MJ; Ghalib, R; Nguyen, BY; Pockros, PJ; Reddy, KR; Robertson, MN; Wahl, J; Wan, S; Zeuzem, S; Zhao, Y | 1 |
| Chen, H; Huang, P; Li, J; Liu, M; Wang, J; Yao, Y; Yu, R; Yue, M; Zang, F; Zhang, Y | 1 |
| Rankin, KV | 1 |
| Catz, SL; Deprey, TM; Halperin, AC; Jack, LM; McAfee, TA; McClure, JB; Richards, J; Swan, GE; Zbikowski, SM | 1 |
| Faessel, HM; Rollema, H; Williams, KE | 1 |
| Bergen, AW; Catz, SL; Conti, DV; Deprey, M; Hinds, DA; Jack, LM; Javitz, HS; McAfee, T; McClure, JB; Michel, M; Richards, J; Stokowksi, RP; Swan, GE; Wessel, J; Zbikowski, SM | 1 |
| Carpenter, MJ; Gray, KM; Klintworth, EM; Lewis, AL; Upadhyaya, HP | 1 |
| Jones, DL; Rankin, KV | 1 |
| Cohen, J; Cui, Q; Elston, D; McFarland, N; McIvor, A; Quan, C; Robinson, L; Smaill, F; Smieja, M; Thabane, L; Zeidler, J | 1 |
| Childs, E; de Wit, H; King, AC; Roche, DJ | 1 |
| Ashare, RL; Blair, IA; Leone, F; Mesaros, AC; Strasser, AA; Tang, KZ | 1 |
| Burstein, AH; Clark, DJ; Faessel, HM; Gibbs, MA; Rohrbacher, K; Stolar, M | 1 |
| Cohen, AF; Dubois, EA; van Bronswijk, H; Zitman, FG | 1 |
| Blessing, JA; Malfetano, J; Muss, HB | 1 |
| Clark, GM; Coltman, CA; Hersh, M; Kuhn, JG; Melink, T; Von Hoff, DD; Weiss, GR | 1 |
| Ahlgren, JD; Andrews, WG; Byrne, PJ; Harvey, JH; McFadden, M; Woolley, PV | 1 |
1 review(s) available for quinoxalines and Nausea
| Article | Year |
|---|---|
Elbasvir/grazoprevir (Zepatier) for hepatitis C.
Topics: Amides; Antiviral Agents; Benzofurans; Carbamates; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Fatigue; Hepatitis C; Humans; Imidazoles; Nausea; Quinoxalines; Sulfonamides | 2016 |
10 trial(s) available for quinoxalines and Nausea
| Article | Year |
|---|---|
Sustainable and equivalent improvements in symptoms and functional well-being following viral cure from ledipasvir/sofosbuvir versus elbasvir/grazoprevir for chronic hepatitis C infection: Findings from the randomized PRIORITIZE trial.
Topics: Amides; Antiviral Agents; Benzimidazoles; Benzofurans; Carbamates; Cyclopropanes; Drug Therapy, Combination; Fatigue; Female; Fluorenes; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Imidazoles; Male; Middle Aged; Nausea; Quinoxalines; Sofosbuvir; Sulfonamides | 2022 |
Safety of varenicline tartrate and counseling versus counseling alone for smoking cessation: a randomized controlled trial for inpatients (STOP study).
Topics: Adult; Aged; Benzazepines; Counseling; Female; Headache; Hospitalization; Humans; Male; Middle Aged; Nausea; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult | 2014 |
Efficacy, safety, pharmacokinetics and pharmacodynamics of SAR245409 (voxtalisib, XL765), an orally administered phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor: a phase 1 expansion cohort in patients with relapsed or refractory lymphoma
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anemia; Area Under Curve; Diarrhea; Drug Resistance, Neoplasm; Exanthema; Female; Humans; Lymphoma; Male; MAP Kinase Signaling System; Metabolic Clearance Rate; Middle Aged; Nausea; Neoplasm Recurrence, Local; Phosphoinositide-3 Kinase Inhibitors; Quinoxalines; Remission Induction; Sulfonamides; TOR Serine-Threonine Kinases; Treatment Outcome; Young Adult | 2015 |
Grazoprevir-Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection: A Randomized Trial.
Topics: Administration, Oral; Adult; Aged; Amides; Antiviral Agents; Benzofurans; Carbamates; Cyclopropanes; Drug Administration Schedule; Drug Therapy, Combination; Fatigue; Female; Genotype; Headache; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Liver Cirrhosis; Male; Middle Aged; Nausea; Quinoxalines; Sulfonamides; Treatment Outcome; Viral Load; Young Adult | 2015 |
Impact of symptoms experienced by varenicline users on tobacco treatment in a real world setting.
Topics: Adult; Benzazepines; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Internet; Male; Middle Aged; Nausea; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Recurrence; Sex Factors; Smoking Cessation; Smoking Prevention; Telephone; Varenicline | 2009 |
Varenicline for smoking cessation: nausea severity and variation in nicotinic receptor genes.
Topics: Benzazepines; Female; Humans; Male; Middle Aged; Nausea; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline | 2012 |
Varenicline versus bupropion XL for smoking cessation in older adolescents: a randomized, double-blind pilot trial.
Topics: Adolescent; Benzazepines; Bupropion; Double-Blind Method; Female; Humans; Male; Nausea; Pilot Projects; Quinoxalines; Sleep Initiation and Maintenance Disorders; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline; Young Adult | 2012 |
Safety and tolerability of varenicline tartrate (Champix(®)/Chantix(®)) for smoking cessation in HIV-infected subjects: a pilot open-label study.
Topics: Adult; Affect; Benzazepines; Cotinine; Dreams; Female; Follow-Up Studies; HIV Seropositivity; Humans; Indicators and Reagents; Male; Middle Aged; Nausea; Nicotinic Agonists; Ontario; Pilot Projects; Prevalence; Quinoxalines; Sleep Initiation and Maintenance Disorders; Smoking; Smoking Cessation; Treatment Outcome; Varenicline | 2012 |
Effects of 21 days of varenicline versus placebo on smoking behaviors and urges among non-treatment seeking smokers.
Topics: Adult; alpha7 Nicotinic Acetylcholine Receptor; Behavior, Addictive; Benzazepines; Biomarkers; Cotinine; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Nausea; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Pennsylvania; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Varenicline; Young Adult | 2012 |
Multiple-dose pharmacokinetics of the selective nicotinic receptor partial agonist, varenicline, in healthy smokers.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Benzazepines; Cotinine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Half-Life; Headache; Humans; Hypotension, Orthostatic; Male; Metabolic Clearance Rate; Middle Aged; Nausea; Nicotine; Patient Dropouts; Quinoxalines; Receptors, Nicotinic; Smoking; Smoking Cessation; Smoking Prevention; Tablets; Varenicline; Vomiting | 2006 |
11 other study(ies) available for quinoxalines and Nausea
| Article | Year |
|---|---|
Varenicline, smoking cessation, and neuropsychiatric adverse events.
Topics: Adult; Aggression; Akathisia, Drug-Induced; Benzazepines; Bupropion; Depression; Female; Humans; Male; Mental Disorders; Nausea; Observational Studies as Topic; Psychomotor Agitation; Quinoxalines; Randomized Controlled Trials as Topic; Risk Factors; Smoking Cessation; Suicidal Ideation; Suicide, Attempted; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2013 |
Increasing the dose of varenicline in patients who do not respond to the standard dose.
Topics: Adult; Aged; Benzazepines; Dose-Response Relationship, Drug; Female; Humans; Male; Medical Records; Middle Aged; Nausea; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Retrospective Studies; Sleep Initiation and Maintenance Disorders; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Vomiting | 2013 |
Grazoprevir and Elbasvir in Patients with Genotype 1 Hepatitis C Virus Infection: A Comprehensive Efficacy and Safety Analysis.
Topics: Amides; Antiviral Agents; Asthenia; Benzofurans; Carbamates; Cyclopropanes; Drug Therapy, Combination; Fatigue; Female; Genotype; Headache; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Male; Middle Aged; Nausea; Quinoxalines; Randomized Controlled Trials as Topic; Ribavirin; RNA, Viral; Sulfonamides; Sustained Virologic Response; Viral Load | 2017 |
New kid on the block: Chantix for smoking cessation.
Topics: Administration, Oral; Benzazepines; Drug Administration Schedule; Drug Approval; Humans; Nausea; Quinoxalines; Receptors, Cholinergic; Receptors, Nicotinic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tablets; Varenicline | 2008 |
Varenicline overdose in a teenager--a clinical pharmacology perspective.
Topics: Adolescent; Benzazepines; Drug Overdose; Humans; Nausea; Poisoning; Quinoxalines; Receptors, Nicotinic; Receptors, Serotonin, 5-HT3; Serotonin Receptor Agonists; Varenicline; Vomiting | 2009 |
Treatment of nicotine dependence with Chantix (varenicline).
Topics: Adult; Benzazepines; Disclosure; Drug Interactions; Humans; Mental Disorders; Nausea; Nicotinic Agonists; Product Surveillance, Postmarketing; Quinoxalines; Randomized Controlled Trials as Topic; Risk Assessment; Safety; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2011 |
Varenicline potentiates alcohol-induced negative subjective responses and offsets impaired eye movements.
Topics: Adult; Affect; Alcohol Drinking; Alcohol-Related Disorders; Benzazepines; Central Nervous System Depressants; Ethanol; Eye Movements; Female; Humans; Male; Nausea; Nicotinic Agonists; Quinoxalines; Varenicline; Young Adult | 2012 |
[New drugs; varenicline].
Topics: Benzazepines; Humans; Nausea; Nicotine; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline | 2007 |
Echinomycin (NSC 526417) in squamous-cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Drug Evaluation; Echinomycin; Female; Humans; Middle Aged; Nausea; Neoplasm Metastasis; Neoplasm Recurrence, Local; Quinoxalines; Uterine Cervical Neoplasms | 1990 |
Phase I trial of echinomycin (NSC 526417), a bifunctional intercalating agent, administered by 24-hour continuous infusion.
Topics: Adult; Aged; Drug Evaluation; Echinomycin; Female; Humans; Infusions, Intravenous; Liver Function Tests; Male; Middle Aged; Nausea; Neoplasms; Platelet Count; Quinoxalines; Thrombocytopenia; Vomiting | 1989 |
Phase I study of echinomycin administered on an intermittent bolus schedule.
Topics: Adult; Aged; Alanine Transaminase; Anaphylaxis; Aspartate Aminotransferases; Droperidol; Drug Administration Schedule; Drug Evaluation; Echinomycin; Female; Hematologic Diseases; Humans; Male; Middle Aged; Nausea; Neoplasms; Quinoxalines | 1985 |